buserelin has been researched along with Uterine Neoplasms in 125 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (28.80) | 18.7374 |
1990's | 77 (61.60) | 18.2507 |
2000's | 9 (7.20) | 29.6817 |
2010's | 3 (2.40) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichigo, S; Imai, A; Matsunami, K; Takagi, H | 1 |
Asano, C; Ichimura, T; Ishiko, O; Kasai, M; Kawamura, N; Matsuda, M; Sumi, T; Sumikura, T | 1 |
Azuma, Y; Deura, I; Harada, T; Higaki, H; Iwabe, T; Taniguchi, F; Terakawa, N | 1 |
Fushiki, S; Honjo, H; Ishihara, H; Kado, N; Kitawaki, J; Koshiba, H | 1 |
Fujimoto, S; Hareyama, H; Hoshi, N; Kataoka, S; Kudo, M; Sakuragi, N; Yamada, H | 1 |
Berlanda, N; Bianchi, S; Carinelli, S; Fedele, L; Zanconato, G | 1 |
Jin, UH; Kim, CH; Kim, DI; Kim, KW; Kim, MS; Kwon, DY; Lee, TK; Lee, YC; Oh, MJ | 1 |
Bastide, A; Fazekas, AT; Guilloteau, C; Lemay, A; Maheux, R | 2 |
Fraser, HM; Healy, DL; Lawson, SL | 1 |
Ishimaru, T; Masuzaki, H; Samejima, T | 1 |
Hando, T; Kurose, T; Shiota, A | 1 |
Balagueró, L; Díez-Gibert, O; Fernández-Montolí, ME; Navarro, MA; Samaniego, JM | 1 |
Aliaga, R; Armero, C; Cano, A; Puértolas, C; Tortajada, M | 1 |
Prelević, GM; Puzigaća, Z; Sretenović, Z | 1 |
Healy, DL; Herington, AC; Pearce, P; Vollenhoven, BJ | 1 |
Ito, M; Katabuchi, H; Miyazaki, K; Okamura, H; Takahashi, M; Tanaka, N; Torashima, M; Yamashita, Y | 1 |
Nakaoka, Y; Ohama, K; Sawasaki, T; Takehara, K; Ueda, K | 1 |
Chou, CY; Lee, WY; Tzeng, CC | 1 |
Chang, MY; Soong, YK; Tsai, FB | 1 |
Fukaya, T; Hoshiai, H; Ishikawa, M; Noda, K; Sawatari, Y | 1 |
Nakamura, Y; Yoshimura, Y | 1 |
Healy, DL; McCloud, P; McDonald, J; Shekleton, P; Vollenhoven, BJ | 1 |
Yoshioka, N | 1 |
Fujii, S; Horiuchi, A; Kobayashi, Y; Mori, A; Nikaido, T; Oguchi, O | 1 |
Okamoto, Y; Seiki, Y; Sugimoto, O; Tsurunaga, T; Ueda, M; Ueki, M | 1 |
Higashijima, T; Kataoka, A; Nishida, T; Yakushiji, M | 1 |
Bühler, K; Gärtner, A; Kuhlmann, M; Regidor, PA; Schindler, AE; Schindler, EM | 1 |
Fujii, S; Horiuchi, A; Iinuma, M; Kobayashi, Y; Nikaido, T; Zhai, YL | 1 |
Minaguchi, H; Taga, M | 1 |
Ichimura, T; Ito, F; Kawamura, N; Ogita, S; Shibata, S; Umesaki, N | 1 |
Kanazawa, K | 1 |
Fujishita, A; Ishimaru, T; Ito, M; Ohtsuru, A; Okazaki, M; Samejima, T; Yamashita, S; Yoshida, M | 1 |
Katabuchi, H; Kitano, Y; Matsuno, Y; Okamura, H; Shimamura, T; Takahashi, M; Yamashita, Y | 1 |
Ishii, M; Kono, T; Taniguchi, S | 1 |
Aoki, R; Banno, K; Iwata, T; Kubushiro, K; Nozawa, S; Tsukazaki, K; Yamashita, H | 1 |
Fukuda, J; Murata, M; Sato, H; Shibata, S; Tanaka, T; Yamamoto, H | 1 |
Haba, T; Honda, KI; Ishiko, O; Kawamura, N; Morimura, M; Ogita, S; Sumi, T; Wakasa, K | 1 |
Kurachi, O; Maruo, T; Matsuo, H; Wang, Y | 1 |
Diedrich, K; Naether, O | 1 |
Acar, B; Posaci, C | 1 |
Deichert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schmidt-Rhode, P; Schulz, KD | 1 |
Aoki, Y; Honma, S; Kanazawa, K; Kodama, S; Kurabayashi, T; Tanaka, K; Yoshiya, N | 1 |
Lemay, A; Maheux, R | 2 |
Clerckx, F; Donnez, J; Gillerot, S; Grandjean, P; Nisolle, M | 1 |
Baird, DT; Lumsden, MA; West, CP | 2 |
Frank, RA; Miller, RM | 1 |
Baird, DT; Hillier, H; Lumsden, MA; Sweeting, V; West, CP | 1 |
Andreoli, C; D'Addato, F; Repinto, A | 1 |
McClelland, HR; Quinn, AJ | 1 |
Altchek, A | 1 |
Benagiano, G; Morini, A; Primiero, FM | 1 |
Asai, M; Masahashi, T; Nakanishi, M; Negoro, Y; Noguchi, M; Suzuki, M; Tomita, A | 1 |
Bukovsky, I; Caspi, E; Golan, A; Koch, Y; Langer, R; Neuman, M | 1 |
Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
Chrisp, P; Goa, KL | 1 |
Minaguchi, H; Mori, J; Uemura, T; Yoshimura, Y | 1 |
Buckler, HM; Chipato, T; Healy, DL; Vollenhoven, B | 1 |
Moghissi, KS | 1 |
Cetera, C; Giorgino, FL | 1 |
Biberoglu, K; Gursoy, R; Yildiz, A | 1 |
Cucuccio, S; De Cecco, L; Leone, M; Messeni Leone, M; Valenzano-Menada, M; Venturini, PL | 1 |
Lauritzen, C; Rossmanith, WG; Sasse, V; Wirth, U | 1 |
Arcaini, L; Baglioni, A; Bianchi, S; Bocciolone, L; Fedele, L; Marchini, M | 1 |
Healy, DL; Hill, D; Lawrence, AS; Paterson, PJ | 1 |
Baba, K; Itoyama, S; Kinoshita, K; Kojima, T; Morita, Y; Sakamoto, S; Takeda, S | 1 |
Ando, M; Nakamura, Y; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
Adamo, R; Artini, PG; Coukos, G; Genazzani, AR; Silferi, M; Volpe, A | 1 |
Abbate, R; Bruni, V; Cirri, R; Coppo, M; Pinto, S; Rosati, D | 1 |
Corbey, RS; Doesburg, WH; Franssen, AM; Rolland, R; van 't Veen, AJ; Willemsen, WN | 1 |
Barbieri-Carones, M; Nencioni, T; Ortolani, S; Penotti, M; Polvani, F; Trevisan, C | 1 |
Ito, M; Okamura, H; Sakoda, Y | 1 |
Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
Cirkel, U; Ochs, H; Schneider, HP; Schweppe, KW | 1 |
Erny, R; Milliet, E | 1 |
Anserini, P; Capitanio, GL; Costa, M; Croce, S; Ferraiolo, A; Remorgida, V | 1 |
Chailurkit, LO; Rojanasakul, A; Sirimongkolkasem, R | 1 |
Bianchi, S; Brioschi, D; Dorta, M; Fedele, L; Vercellini, P | 1 |
Loong, EP; Wong, FW | 1 |
Healy, DL; McDonald, J; Shekleton, P; Vollenhoven, BJ | 1 |
Bourgonjon, D; Casanas-Roux, F; Clerckx, F; Donnez, J; Gillerot, S; Nisolle, M | 1 |
Ayala Ruiz, A; Bustos, HH; Contreras, J; López Garcia, R; Sánchez, V | 1 |
Ando, M; Maruyama, K; Nakamura, Y; Nanno, T; Suzuki, M; Takahashi, K; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
Deichert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schulz, KD; Sturm, G | 1 |
Firichenko, VI; Vasil'chenko, NP | 1 |
Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R | 1 |
Anserini, P; Costantini, S; De Cecco, L; Remorgida, V; Valenzano, M; Venturini, PL | 1 |
Barbieri, RL; Friedman, AJ; Lobel, SM; Rein, MS | 1 |
Caruso, A; Dell'Acqua, S; Lanzone, A; Mancuso, S; Marana, R; Muscatello, P; Muzii, L | 1 |
Arcaini, L; Bianchi, S; Candiani, GB; Candiani, M; Fedele, L; Vercellini, P | 1 |
Adelberger, V; Breckwoldt, M; Geisthövel, F; Wieacker, P | 1 |
Matta, WH; Nye, M; Shaw, RW | 1 |
Clerckx, F; Donnez, J; Gillerot, S; Sandow, J; Schrurs, B | 1 |
Kimura, A; Minaguchi, H; Shirasu, K; Uemura, T | 1 |
Anserini, P; Bianchi, G; Costantini, S; De Cecco, L; Fagà, L; Menada, MV; Monteforte, P; Rovetta, G | 1 |
Philipp, K; Reichel, R; Spona, J | 1 |
Cirkel, U; Hanker, JP; Ochs, H; Schneider, HP; Schweppe, KW | 1 |
Diechert, U; Duda, V; Gesenhues, T; Hackenberg, R; Schulz, KD; Sturm, G | 1 |
Gardner, RL; Shaw, RW | 1 |
Baird, DT; Bramley, TA; Hawkins, RA; Lumsden, MA; Rumgay, L; West, CP | 1 |
Fieggan, AG; Pienaar, CA; Van der Spuy, ZM; Wood, MJ | 1 |
Shaw, RW | 2 |
Baird, DT; Bramley, TA; Hawkins, TA; Lumsden, MA; West, CP | 1 |
Hazum, E; Insler, V; Levy, J; Marbach, M; Sharoni, Y; Wiznitzer, A | 1 |
Lemay, A | 1 |
Baird, DT; Lawson, S; Lumsden, MA; West, CP; Williamson, J | 1 |
Campbell, S; Matta, WH; Shaw, RW; Stabile, I | 1 |
Baird, DT; Bramley, T; Lumsden, MA; Rumgay, L; West, CP | 1 |
Burger, HG; Healy, DL; McLachlan, RI | 1 |
Abdulwahid, NA; Craft, I; Hague, WM; Jacobs, HS | 1 |
Abbott, M; Baird, DT; Fraser, HM; Healy, DL; Lawson, SR | 1 |
Fujii, S; Konishi, I; Mori, T | 1 |
Inoue, T; Kigawa, T; Matsuoka, R; Mori, H | 1 |
Corbey, RS; Franssen, AM; Rolland, R; Willemsen, WN | 1 |
Matta, W; Shaw, RW | 1 |
Lemay, A; Maheux, R; Merat, P | 1 |
Baird, DT; Fraser, HM | 1 |
Farid, NR; Jean, C; Maheux, R; Parent, JG; Samson, Y | 1 |
Lemay, A; Maheux, R; Turcot-Lemay, L | 1 |
Sugimoto, O | 1 |
Pepperell, RJ | 1 |
10 review(s) available for buserelin and Uterine Neoplasms
Article | Year |
---|---|
Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist.
Topics: Adult; Buserelin; Estrogens; Fallopian Tubes; Female; Follow-Up Studies; Humans; Hysterectomy; Leiomyomatosis; Leiomyosarcoma; Lymph Node Excision; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Ovariectomy; Pelvis; Uterine Hemorrhage; Uterine Neoplasms | 1994 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Topics: Buserelin; Endometriosis; Female; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1992 |
Management of fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Leuprolide; Methods; Uterine Neoplasms | 1992 |
Fibroids: overview of current and future treatment options.
Topics: Buserelin; Female; Humans; Leiomyoma; Myometrium; Uterine Neoplasms | 1992 |
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Topics: Animals; Breast Neoplasms; Buserelin; Drug Evaluation; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Humans; Leiomyoma; Male; Menstruation Disturbances; Polycystic Ovary Syndrome; Prostatic Neoplasms; Uterine Neoplasms | 1991 |
Hormonal therapy before surgical treatment for uterine leiomyomas.
Topics: Antineoplastic Agents; Buserelin; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Nafarelin; Premedication; Uterine Neoplasms | 1991 |
[Treatment of patients with uterine myoma and its effectiveness].
Topics: Adult; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Hysterectomy; Leiomyoma; Middle Aged; Uterine Neoplasms | 1990 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
Clinical applications of LHRH analogues.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Leiomyoma; Male; Ovulation; Ovulation Induction; Premenstrual Syndrome; Prostatic Neoplasms; Puberty, Precocious; Uterine Neoplasms; Uterus | 1987 |
23 trial(s) available for buserelin and Uterine Neoplasms
Article | Year |
---|---|
GnRHa and steroid add-back therapy for uterine myoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Middle Aged; Time Factors; Uterine Neoplasms | 1995 |
[Clinical usefulness of GnRH agonist therapy for premenopausal women with uterine leiomyoma].
Topics: Buserelin; Drug Administration Schedule; Female; Humans; Leiomyoma; Middle Aged; Premenopause; Uterine Neoplasms | 1995 |
Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Topics: Adult; Buserelin; Cytosol; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hysterectomy; Leiomyoma; Luteinizing Hormone; Middle Aged; Myometrium; Premenopause; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1995 |
Influence of the ovary on parameters of LH secretion during the recovery from buserelin-induced desensitization.
Topics: Administration, Intranasal; Adult; Buserelin; Female; Humans; Hysterectomy; Leiomyomatosis; Luteinizing Hormone; Middle Aged; Ovariectomy; Ovary; Premenopause; Radioimmunoassay; Remission Induction; Uterine Neoplasms | 1994 |
Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
Topics: Administration, Intranasal; Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Hemoglobins; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Ultrasonography; Uterine Neoplasms | 1993 |
Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Danazol; Estrogen Antagonists; Female; Humans; Leiomyoma; Middle Aged; Uterine Neoplasms | 1995 |
Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
Topics: Adult; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1992 |
Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin.
Topics: Administration, Intranasal; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Bone Density; Buserelin; Endometriosis; Estrogens; Female; Follicle Stimulating Hormone; Humans; Laparoscopy; Leiomyoma; Lipids; Luteinizing Hormone; Menstruation; Progesterone; Prolactin; Serum Albumin; Uterine Neoplasms | 1991 |
Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up.
Topics: Administration, Intranasal; Adult; Analysis of Variance; Buserelin; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Middle Aged; Uterine Neoplasms | 1991 |
Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Topics: Adult; Bone and Bones; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Random Allocation; Retrospective Studies; Uterine Neoplasms; Uterus | 1991 |
Changes in thromboxane A2 generation and plasma lipid pattern in pseudomenopause induced by gonadotropin releasing hormone (GnRH) analogue buserelin.
Topics: Adult; Blood Coagulation; Blood Platelets; Buserelin; Female; Gonadal Steroid Hormones; Humans; Leiomyoma; Lipids; Menopause; Middle Aged; Thromboxane A2; Uterine Neoplasms | 1991 |
Gonadotropin releasing hormone agonist therapy and its effect on bone mass.
Topics: Adult; Amenorrhea; Bone Density; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Time Factors; Uterine Neoplasms | 1991 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence.
Topics: Adult; Buserelin; Combined Modality Therapy; Female; Humans; Leiomyoma; Myometrium; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Uterine Neoplasms; Uterus | 1990 |
Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
Topics: Administration, Intranasal; Adult; Aging; Buserelin; Female; Forecasting; Humans; Injections, Subcutaneous; Leiomyoma; Middle Aged; Prospective Studies; Uterine Neoplasms | 1990 |
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Buserelin; Chi-Square Distribution; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Leiomyoma; Luteinizing Hormone; Random Allocation; Ultrasonography; Uterine Neoplasms | 1990 |
Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Topics: Buserelin; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Preoperative Care; Progestins; Time Factors; Uterine Neoplasms; Uterus | 1990 |
Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
Topics: Adult; Anemia, Hypochromic; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Leiomyoma; Menorrhagia; Middle Aged; Uterine Neoplasms | 1990 |
[GnRH-analogs in the therapy of uterine myomatosis].
Topics: Adult; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms | 1990 |
Goserelin therapy before surgery for uterine fibroids.
Topics: Adult; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Leiomyoma; Middle Aged; Pilot Projects; Premedication; Uterine Neoplasms | 1987 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.
Topics: Administration, Intranasal; Adult; Buserelin; Clinical Trials as Topic; Female; Humans; Injections, Subcutaneous; Leiomyoma; Middle Aged; Neoplasms, Multiple Primary; Time Factors; Uterine Neoplasms | 1987 |
Will gonadotrophin releasing hormone analogues profoundly affect gynaecological practice?
Topics: Amenorrhea; Buserelin; Clinical Trials as Topic; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Male; Ovulation; Prostatic Neoplasms; Uterine Neoplasms | 1985 |
93 other study(ies) available for buserelin and Uterine Neoplasms
Article | Year |
---|---|
Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
Topics: Adenomyosis; Adult; Biomarkers; Bone Remodeling; Bone Resorption; Buserelin; Diphosphonates; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Retrospective Studies; Uterine Neoplasms | 2016 |
Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens.
Topics: Adult; Biopsy, Needle; Buserelin; Female; Humans; Leiomyoma; Middle Aged; Predictive Value of Tests; Prospective Studies; Uterine Neoplasms; Vascular Endothelial Growth Factor A | 2012 |
Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.
Topics: Adult; Blotting, Western; Buserelin; Cell Proliferation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Interleukin-8; Leiomyoma; Ovarian Diseases; Premenopause; Receptors, LHRH; Stromal Cells; Tumor Necrosis Factor-alpha; Uterine Neoplasms | 2013 |
Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase; Buserelin; Danazol; Endometriosis; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; In Vitro Techniques; Ki-67 Antigen; Leiomyoma; Leuprolide; Middle Aged; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; RNA, Neoplasm; Uterine Diseases; Uterine Neoplasms | 2003 |
Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa-response in relation to chromosome karyotype.
Topics: Adult; Buserelin; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 7; Female; Gonadotropin-Releasing Hormone; Humans; Karyotyping; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Nafarelin; Uterine Neoplasms | 2003 |
Conservative treatment of diffuse uterine leiomyomatosis.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Laparotomy; Leiomyoma; Menorrhagia; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms | 2004 |
Antiproliferative effect of Scutellaria barbata D. Don. on cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein.
Topics: Animals; Blotting, Western; Buserelin; Cell Proliferation; Down-Regulation; Female; Fetal Development; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Male; Phorbol Esters; Plant Extracts; Pregnancy; Progesterone; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; Scutellaria; Tumor Cells, Cultured; Uterine Neoplasms | 2008 |
Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Progesterone; Ultrasonics; Uterine Neoplasms | 1984 |
Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.
Topics: Adult; Buserelin; Female; Humans; Infusions, Parenteral; Leiomyoma; Uterine Neoplasms | 1984 |
Differential reduction in the volume of leiomyoma and uterus during buserelin treatment.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Ultrasonography; Uterine Neoplasms; Uterus | 1994 |
Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Myometrium; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Uterine Neoplasms | 1994 |
Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Topics: Buserelin; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Leiomyoma; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Uterine Neoplasms; Uterus | 1993 |
[Two cases of hypovolemic shock by massive bleeding associated with submucous leiomyoma during buserelin treatment].
Topics: Buserelin; Female; Humans; Leiomyoma; Middle Aged; Shock; Uterine Neoplasms | 1993 |
Infarcted intramural uterine leiomyomata during buserelin acetate treatment.
Topics: Adult; Buserelin; Female; Humans; Infarction; Leiomyoma; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms | 1993 |
Laparoscopic evaluation of the onset and progression of endometriosis.
Topics: Adolescent; Adult; Buserelin; Colorectal Neoplasms; Danazol; Endometriosis; Fallopian Tube Neoplasms; Female; Fertility; Humans; Infertility; Laparoscopy; Ovarian Neoplasms; Pelvic Neoplasms; Retrospective Studies; Uterine Neoplasms | 1993 |
An open study of luteinizing hormone releasing hormone agonists in infertile women with uterine fibroids.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Myometrium; Pregnancy; Uterine Neoplasms | 1993 |
[Usefulness of Doppler ultrasound in predicting the effect of gonadotropin-releasing hormone agonist (GnRHa) on myoma uteri].
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Predictive Value of Tests; Regional Blood Flow; Ultrasonography, Doppler, Pulsed; Uterine Neoplasms; Uterus; Vascular Resistance | 1995 |
Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue.
Topics: Adult; Buserelin; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Menstrual Cycle; Middle Aged; Postmenopause; Uterine Neoplasms | 1995 |
Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
Topics: Adult; Aged; Apoptosis; Buserelin; Female; Humans; Japan; Leiomyoma; Lewis Blood Group Antigens; Middle Aged; Postmenopause; Premenopause; Uterine Neoplasms | 1996 |
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Infertility, Female; Injections, Intramuscular; Leiomyoma; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Retrospective Studies; Time Factors; Triptorelin Pamoate; Uterine Neoplasms | 1997 |
Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues.
Topics: Base Sequence; Buserelin; CDC2-CDC28 Kinases; Cell Division; Culture Techniques; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; G1 Phase; Gene Expression; Humans; Leiomyoma; Microscopy, Phase-Contrast; Muscle, Smooth; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Receptors, LHRH; RNA, Messenger; Uterine Neoplasms | 1997 |
Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administration.
Topics: Adult; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Resorption; Buserelin; Collagen; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Leiomyoma; Middle Aged; Nafarelin; Uterine Neoplasms | 1997 |
Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Biopsy; Buserelin; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Treatment Outcome; Uterine Neoplasms | 1997 |
Trophoblastic disease: twenty years' experience at Niigata University.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Choriocarcinoma; Female; Humans; Japan; Pregnancy; Prognosis; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms | 1998 |
Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas.
Topics: Adult; Buserelin; Cell Division; Female; Humans; Hysterectomy; Immunoenzyme Techniques; Leiomyoma; Middle Aged; Muscle, Smooth; Parathyroid Hormone-Related Protein; Proliferating Cell Nuclear Antigen; Proteins; Receptor, Parathyroid Hormone, Type 1; Receptors, Parathyroid Hormone; RNA, Messenger; Uterine Neoplasms | 1999 |
Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
Topics: Administration, Inhalation; Adult; Antineoplastic Agents, Hormonal; Buserelin; Female; Humans; Leiomyomatosis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Treatment Outcome; Uterine Neoplasms | 1999 |
Intranasal buserelin acetate-induced pigmented roseola-like eruption.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Drug Eruptions; Female; Humans; Leiomyomatosis; Middle Aged; Patch Tests; Uterine Neoplasms | 2000 |
Gonadotropin-releasing hormone analogue therapy for peritoneal inclusion cysts after gynecological surgery.
Topics: Adult; Buserelin; Cysts; Female; Genitalia, Female; Humans; Hysterectomy; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Ovariectomy; Peritoneal Diseases; Postoperative Complications; Recurrence; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2000 |
Involvement of annexin V in the antiproliferative effect of GnRH agonist on cultured human uterine leiomyoma cells.
Topics: Annexin A5; Base Sequence; Buserelin; Cell Division; DNA Primers; Enzyme Activation; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Protein Kinase C; Receptors, LHRH; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Uterine Neoplasms | 2001 |
Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Cervix Uteri; Epithelium; Female; Fluorescent Antibody Technique; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Staining and Labeling; Tolonium Chloride; Uterine Neoplasms | 2001 |
Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Western; Buserelin; Cell Count; Cell Division; Cell Separation; Colorimetry; Down-Regulation; fas Receptor; Female; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Leiomyoma; Proliferating Cell Nuclear Antigen; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Up-Regulation; Uterine Neoplasms | 2002 |
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Clinical application of a gonadotropin releasing hormone analog (buserelin) in the treatment of uterine leiomyomas.
Topics: Buserelin; Estradiol; Female; Humans; Injections, Subcutaneous; Leiomyoma; Remission Induction; Uterine Neoplasms | 1992 |
The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.
Topics: Buserelin; Estradiol; Female; Goserelin; Humans; Leiomyoma; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms | 1992 |
[Serum level of hCG-like substance in the patients of choriocarcinoma can be suppressed by Buserelin-administration].
Topics: Administration, Intranasal; Adult; Buserelin; Choriocarcinoma; Chorionic Gonadotropin; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Pregnancy; Remission Induction; Uterine Neoplasms | 1992 |
Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.
Topics: Adult; Bone Density; Buserelin; Climacteric; Delayed-Action Preparations; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Follow-Up Studies; Goserelin; Humans; Leiomyoma; Middle Aged; Uterine Neoplasms | 1992 |
The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques.
Topics: Adult; Buserelin; Combined Modality Therapy; Endometriosis; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Myometrium; Ovarian Neoplasms; Prospective Studies; Uterine Neoplasms | 1992 |
Pre-surgical treatment of uterine myomas with LH-RH agonists.
Topics: Administration, Inhalation; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Chemotherapy, Adjuvant; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Injections, Intramuscular; Leiomyoma; Leuprolide; Luteinizing Hormone; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms | 1992 |
Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
Topics: Adult; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Leiomyoma; Middle Aged; Preoperative Care; Uterine Neoplasms | 1992 |
[Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue].
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Calcitonin; Calcium; Endometriosis; Female; Humans; Middle Aged; Osteocalcin; Parathyroid Hormone; Uterine Neoplasms | 1992 |
Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Receptors, LHRH; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
Topics: Adult; Buserelin; Female; Humans; Hyalin; Leiomyoma; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1991 |
Pelvic pain complicating LHRH analogue treatment of fibroids.
Topics: Adult; Buserelin; Female; Humans; Leiomyoma; Pain; Pelvis; Uterine Neoplasms | 1991 |
Pretreatment with Zoladex improves surgery for uterine fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Hysterectomy; Leiomyoma; Premedication; Uterine Neoplasms | 1991 |
The management of leiomyoma uteri by GnRH analogues.
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Goserelin; Hemoglobins; Humans; Leiomyoma; Middle Aged; Pregnancy; Remission Induction; Ultrasonography; Uterine Neoplasms | 1991 |
Immunohistochemical localization of epidermal growth factor receptor in leiomyomas from women treated with goserelin depot.
Topics: Adult; Buserelin; Delayed-Action Preparations; ErbB Receptors; Female; Goserelin; Humans; Immunohistochemistry; Leiomyoma; Middle Aged; Myometrium; Ultrasonography; Uterine Neoplasms | 1991 |
[Differential effects of GnRH analogs on androgen concentrations in females].
Topics: Adult; Androgens; Antineoplastic Agents; Buserelin; Drug Implants; Endometriosis; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Injections, Intramuscular; Leiomyoma; Luteinizing Hormone; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
Management of submucous uterine fibroid with buserelin, gemeprost and hysteroscopic resection.
Topics: Adult; Alprostadil; Buserelin; Cervix Uteri; Dilatation; Female; Humans; Hysteroscopy; Leiomyoma; Menorrhagia; Pessaries; Uterine Neoplasms | 1991 |
[Effects of buserelin presurgical treatment on vascularity in the sub-serosal interstitial tissue of the uterus and operative blood loss at hysterectomy in women with uterine leiomyoma and adenomyosis].
Topics: Blood Loss, Surgical; Buserelin; Danazol; Endometriosis; Female; Humans; Hysterectomy; Leiomyoma; Mucous Membrane; Preoperative Care; Uterine Neoplasms; Uterus | 1991 |
Pregnancy following regression of uterine submucosal leiomyoma with GnRH therapy; a case report.
Topics: Abortion, Spontaneous; Adult; Buserelin; Female; Humans; Infertility, Female; Insemination, Artificial, Homologous; Leiomyoma; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms | 1991 |
Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
Topics: Adult; Bone Resorption; Buserelin; Cholesterol; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Infusion Pumps; Injections, Subcutaneous; Leiomyoma; Luteinizing Hormone; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Buserelin; Estradiol; Female; Humans; Leiomyoma; Menopause; Middle Aged; Osteoporosis; Receptors, LHRH; Uterine Neoplasms; Uterus | 1990 |
[Residual endometriosis following LHRH analog therapy].
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Uterine Neoplasms; Uterus | 1990 |
[Treatment of uterine fibroma using LH-RH analogs and gestrinone. Limits and indications].
Topics: Administration, Intranasal; Adolescent; Adult; Buserelin; Female; Gestrinone; Humans; Leiomyoma; Middle Aged; Norpregnatrienes; Remission Induction; Uterine Neoplasms | 1990 |
Comparison of different ovarian stimulation protocols for gamete intrafallopian transfer in patients with minimal and mild endometriosis.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Endometriosis; Estradiol; Female; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Ovulation Induction; Prospective Studies; Uterine Neoplasms | 1990 |
Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Gonadotropins, Pituitary; Humans; Progesterone; Uterine Neoplasms | 1990 |
Uterine leiomyosarcoma diagnosed during treatment with agonist of luteinizing hormone-releasing hormone for presumed uterine fibroid.
Topics: Administration, Inhalation; Adult; Buserelin; Diagnosis, Differential; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leiomyosarcoma; Male; Uterine Neoplasms | 1990 |
[Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant)].
Topics: Administration, Intranasal; Adult; Buserelin; Danazol; Endometriosis; Female; Gestrinone; Humans; Preoperative Care; Prospective Studies; Uterine Neoplasms | 1990 |
[Medical treatment of uterine leiomyomatosis with an agonist of pituitary gonadotropins (GnRH). Presentation of a case].
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Pregnancy; Radiography; Uterine Neoplasms | 1990 |
[Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Bone Density; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Uterine Neoplasms | 1990 |
[Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Topics: Adult; Buserelin; Combined Modality Therapy; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Leiomyoma; Luteinizing Hormone; Progesterone; Ultrasonography; Uterine Neoplasms; Uterus | 1990 |
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms | 1990 |
Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Buserelin; Endometriosis; Female; Humans; Laparoscopy; Prospective Studies; Time Factors; Uterine Neoplasms | 1990 |
Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin.
Topics: Adult; Buserelin; Estradiol; Female; Follow-Up Studies; Humans; Leiomyoma; Middle Aged; Uterine Neoplasms; Uterus | 1989 |
Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
Topics: Adult; Buserelin; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hysterosalpingography; Leiomyoma; Luteinizing Hormone; Pregnancy; Uterine Neoplasms | 1989 |
[Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].
Topics: Administration, Intranasal; Adult; Buserelin; Drug Evaluation; Estradiol; Female; Humans; Leiomyoma; Middle Aged; Remission Induction; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Effects of gonadotrophin-releasing hormone agonist on uterine fibroids and bone density.
Topics: Adult; Bone Density; Buserelin; Estradiol; Female; Humans; Leiomyoma; Middle Aged; Time Factors; Uterine Neoplasms | 1989 |
[Long-term follow-up of 14 patients with endometriosis, who were treated with the LHRH analog buserelin].
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Infertility, Female; Uterine Neoplasms | 1989 |
LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.
Topics: Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Uterine Neoplasms | 1989 |
[New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Leiomyoma; Neoplasms, Hormone-Dependent; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Cornual fibroids: a conservative approach to restoring tubal patency using a gonadotropin-releasing hormone agonist (goserelin) with successful pregnancy.
Topics: Adult; Buserelin; Fallopian Tube Patency Tests; Fallopian Tubes; Female; Fibroma; Goserelin; Humans; Pregnancy; Uterine Neoplasms | 1989 |
The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Topics: Buserelin; Estradiol; Female; Goserelin; Humans; Leiomyoma; Menstrual Cycle; Myometrium; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Uterine Neoplasms; Uterus | 1989 |
The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1989 |
Mechanism of LHRH analogue action in uterine fibroids.
Topics: Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Uterine Neoplasms | 1989 |
Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
Topics: Buserelin; ErbB Receptors; Female; Goserelin; Humans; Leiomyoma; Receptors, Estradiol; Receptors, Progesterone; Uterine Neoplasms | 1989 |
Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
Topics: Adult; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Molecular Weight; Receptors, LHRH; Thyrotropin-Releasing Hormone; Triptorelin Pamoate; Uterine Neoplasms; Uterus | 1988 |
Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1987 |
Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
Topics: Adult; Buserelin; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Menstruation; Middle Aged; Ovulation; Time Factors; Uterine Neoplasms | 1987 |
Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.
Topics: Adult; Buserelin; Drug Evaluation; Female; Humans; Leiomyoma; Regional Blood Flow; Rheology; Time Factors; Uterine Neoplasms; Uterus | 1988 |
GnRH agonists-antagonists--clinical applications.
Topics: Buserelin; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Osteolysis; Polycystic Ovary Syndrome; Uterine Neoplasms | 1988 |
The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
Topics: Adult; Buserelin; Epidermal Growth Factor; Estradiol; Female; Goserelin; Humans; Leiomyoma; Menstrual Cycle; Myometrium; Uterine Neoplasms | 1988 |
Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma.
Topics: Adult; Buserelin; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Ovary; Uterine Neoplasms | 1986 |
Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
Topics: Adult; Buserelin; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteal Phase; Luteinizing Hormone; Middle Aged; Progesterone; Uterine Neoplasms | 1986 |
[Pathogenesis and conservative therapy of uterine leiomyoma].
Topics: Buserelin; Danazol; Estrogens; Female; Gestrinone; Humans; Leiomyoma; Progesterone; Uterine Neoplasms | 1986 |
[Inhibitory effect of prolactin secretion by luteinizing hormone releasing hormone agonist (buserelin)].
Topics: Administration, Intranasal; Adult; Buserelin; Depression, Chemical; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Prolactin; Uterine Neoplasms | 1986 |
Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
Topics: Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Uterine Neoplasms | 1986 |
Uterine leiomyoma: treatment with LHRH agonist.
Topics: Adult; Buserelin; Combined Modality Therapy; Danazol; Estradiol; Female; Follicle Stimulating Hormone; Humans; Laser Therapy; Leiomyoma; Luteinizing Hormone; Middle Aged; Progestins; Uterine Neoplasms | 1986 |
Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Topics: Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Menstruation; Uterine Neoplasms | 1986 |
Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Buserelin; Dyspnea; Estradiol; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Pain; Uterine Neoplasms | 1987 |
Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Luteinizing Hormone; Middle Aged; Uterine Neoplasms | 1988 |
[Medical treatment of endometriosis].
Topics: Buserelin; Danazol; Endometriosis; Female; Gestrinone; Humans; Norpregnatrienes; Pregnadienes; Uterine Neoplasms | 1985 |
Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
Topics: Adult; Buserelin; Climacteric; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Middle Aged; Pilot Projects; Progesterone; Uterine Hemorrhage; Uterine Neoplasms | 1985 |